<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
</head>
<body>
<p>Hi Melissa,</p>
<p>Tx you for your detailed recent emails. I have a question. As
I understand it, we start our discussion tomorrow on Discussion
Draft v2, <b>Section IV</b>, Evaluating a Closed Generic gTLD
Application,
<a class="moz-txt-link-freetext" href="https://docs.google.com/document/d/1wtLVcyWhyrCaYl1iqlAncaIyrqpS--0aPCTjpwMue7I/edit">https://docs.google.com/document/d/1wtLVcyWhyrCaYl1iqlAncaIyrqpS--0aPCTjpwMue7I/edit</a></p>
<p>If that is right, then after Section IV, we move to Section V,
Contracting & Post-Delegation Review. <i>After Section V, do
we return to the top of the document, the summary </i>Sections
I and II, General Principles and Definitions <i>or will these
summary sections be revised or replaced in light of our recent
and upcoming work in Sections III to V? <br>
</i></p>
<p>Best and tx, Kathy</p>
<p>On 4/28/2023 2:48 PM, Melissa Peters Allgood wrote:<br>
</p>
<blockquote type="cite"
cite="mid:CC9098B2-6A6B-48C9-B115-390B457FFE0D@icann.org">
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta name="Generator" content="Microsoft Word 15 (filtered
medium)">
<style>@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}@font-face
{font-family:"Times New Roman \(Body CS\)";
panose-1:2 11 6 4 2 2 2 2 2 4;}p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:12.0pt;
font-family:"Calibri",sans-serif;}a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}.MsoChpDefault
{mso-style-type:export-only;
font-size:12.0pt;
font-family:"Calibri",sans-serif;}div.WordSection1
{page:WordSection1;}</style>
<div class="WordSection1">
<div>
<div>
<p class="MsoNormal">Hello again, <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">As I mentioned in my email about
timeline, we ask you incorporate the following two
documents into your Closed Generics efforts moving
forward.
<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><a
href="https://docs.google.com/document/d/14Iw5dya1WywzeuVBjBfSYDQ80MT-2wCJNPbeNl4kbzw/edit"
moz-do-not-send="true">Red Line Table</a><o:p></o:p></b></p>
<p class="MsoNormal">We’ve asked you add the rationale for
any red lines you have in this table. In the interest of
time, areas that saw broad agreement during our red line
discussions have been included (or excluded depending on
the question) into the clean v3 document below. Areas that
did not see broad agreement during our red line
discussions will be subject to follow up in the coming
days.
<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><a
href="https://docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit"
moz-do-not-send="true">Closed Generics Framework v3
(Clean Document)</a><o:p></o:p></b></p>
<p class="MsoNormal">Specific areas where the group
indicated broad agreement that a given issue was a must
include red line have been placed in this document. This
includes issues that fall into the Notable Concern
category of our red line discussions (implementability,
covered by SubPro, the issue was in the wrong section of
the framework, duplicative of the guidebook, or specific
concerns with the text but not the issue itself). We will
continue to work through these Notable Concerns in the
coming days. Please do not comment or edit this document.
<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b><u>Next Call<o:p></o:p></u></b></p>
<p class="MsoNormal">I hope we can conclude the remaining
red line discussions within Discussion Draft v2 during our
next call, Wednesday, May 3 at 20:00 UTC and move onto
focused discussions on those red line areas that have not
seen broad support.
<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Wishing you all a lovely weekend, <o:p></o:p></p>
<p class="MsoNormal">Melissa <o:p></o:p></p>
</div>
</div>
</div>
<br>
<fieldset class="moz-mime-attachment-header"></fieldset>
<pre class="moz-quote-pre" wrap="">_______________________________________________
gnso-gac-closed-generics mailing list
<a class="moz-txt-link-abbreviated" href="mailto:gnso-gac-closed-generics@icann.org">gnso-gac-closed-generics@icann.org</a>
<a class="moz-txt-link-freetext" href="https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics">https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics</a>
_______________________________________________
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a class="moz-txt-link-freetext" href="https://www.icann.org/privacy/policy">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a class="moz-txt-link-freetext" href="https://www.icann.org/privacy/tos">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.</pre>
</blockquote>
</body>
</html>